Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,629,089
-$4,348,765 QoQ
Shares Held
387,650
-20.2% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99.69044240938992.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3095575906100864.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. ACAD ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in ACAD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,629,089 | 387,650 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,977,854 | 485,880 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,407,022 | 909,420 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,785,738 | 685,477 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,889,922 | 354,601 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,660,184 | 253,961 | Shares | Defined | 2025-02-11 | |
| 2024-06-30 | $581,928 | 35,811 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,834,796 | 1,072,731 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $13,873,961 | 443,116 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,827,517 | 327,616 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,818,252 | 159,426 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $757,053 | 40,226 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $282,962 | 17,296 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $372,412 | 26,431 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $574,764 | 23,731 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $230,365 | 9,870 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $173,740 | 10,460 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $247,558 | 10,150 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $2,997,768 | 56,075 | Shares | Defined | 2021-08-16 | |
| 2020-06-30 | $10,372 | 214 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $6,717 | 159 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||